Anti-B-Cell Maturation Antigen BiTE Molecule AMG 420 Induces Responses in Multiple Myeloma
Topp, Max S, Duell, Johannes, Zugmaier, Gerhard, Attal, Michel, Moreau, Philippe, Langer, Christian, Krönke, Jan, Facon, Thierry, Salnikov, Alexey V, Lesley, Robin, Beutner, Karl, Kalabus, James, Rasmussen, Erik, Riemann, Kathrin, Minella, Alex C, Munzert, Gerd, Einsele, Hermann
Published in Journal of clinical oncology (10.03.2020)
Published in Journal of clinical oncology (10.03.2020)
Get full text
Journal Article
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
Kantarjian, Hagop, Stein, Anthony, Gökbuget, Nicola, Fielding, Adele K, Schuh, Andre C, Ribera, Josep-Maria, Wei, Andrew, Dombret, Hervé, Foà, Robin, Bassan, Renato, Arslan, Önder, Sanz, Miguel A, Bergeron, Julie, Demirkan, Fatih, Lech-Maranda, Ewa, Rambaldi, Alessandro, Thomas, Xavier, Horst, Heinz-August, Brüggemann, Monika, Klapper, Wolfram, Wood, Brent L, Fleishman, Alex, Nagorsen, Dirk, Holland, Christopher, Zimmerman, Zachary, Topp, Max S
Published in The New England journal of medicine (02.03.2017)
Published in The New England journal of medicine (02.03.2017)
Get full text
Journal Article
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
Topp, Max S, Dr, Gökbuget, Nicola, MD, Stein, Anthony S, MD, Zugmaier, Gerhard, MD, O'Brien, Susan, MD, Bargou, Ralf C, Prof, Dombret, Hervé, MD, Fielding, Adele K, PhD, Heffner, Leonard, MD, Larson, Richard A, Prof, Neumann, Svenja, MD, Foà, Robin, MD, Litzow, Mark, Prof, Ribera, Josep-Maria, Prof, Rambaldi, Alessandro, MD, Schiller, Gary, MD, Brüggemann, Monika, MD, Horst, Heinz A, MD, Holland, Chris, MS, Jia, Catherine, PhD, Maniar, Tapan, MD, Huber, Birgit, PhD, Nagorsen, Dirk, MD, Forman, Stephen J, MD, Kantarjian, Hagop M, Prof
Published in The lancet oncology (01.01.2015)
Published in The lancet oncology (01.01.2015)
Get full text
Journal Article
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S, Schäfer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josée M, Keller, Ulrich Bernd, Krause, Stefan W, Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Dührsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter, Engert, Andreas
Published in Journal of clinical oncology (01.11.2019)
Published in Journal of clinical oncology (01.11.2019)
Get full text
Journal Article
Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT
Duell, Johannes, Krummenast, Franziska, Schirbel, Andreas, Klassen, Philipp, Samnick, Samuel, Rauert-Wunderlich, Hilka, Rasche, Leo, Buck, Andreas K, Wester, Hans-Jürgen, Rosenwald, Andreas, Einsele, Herrmann, Topp, Max S, Lapa, Constantin, Kircher, Malte
Published in Journal of Nuclear Medicine (01.10.2021)
Published in Journal of Nuclear Medicine (01.10.2021)
Get full text
Journal Article
Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
TOPP, Max S, KUFER, Peter, STELLJES, Matthias, SCHAICH, Markus, DEGENHARD, Evelyn, KÖHNE-VOLLAND, Rudolf, BRÜGGEMANN, Monika, OTTMANN, Oliver, PFEIFER, Heike, BURMEISTER, Thomas, NAGORSEN, Dirk, SCHMIDT, Margit, GÖKBUGET, Nicola, LUTTERBUESE, Ralf, REINHARDT, Carsten, BAEUERLE, Patrick A, KNEBA, Michael, EINSELE, Hermann, RIETHMÜLLER, Gert, HOELZER, Dieter, ZUGMAIER, Gerhard, BARGOU, Ralf C, GOEBELER, Mariele, KLINGER, Matthias, NEUMANN, Svenja, HORST, Heinz-A, RAFF, Thorsten, VIARDOT, Andreas, SCHMID, Mathias
Published in Journal of clinical oncology (20.06.2011)
Published in Journal of clinical oncology (20.06.2011)
Get full text
Journal Article
Hematopoietic stem cell involvement in BCR-ABL1–positive ALL as a potential mechanism of resistance to blinatumomab therapy
Nagel, Inga, Bartels, Marius, Duell, Johannes, Oberg, Hans-Heinrich, Ussat, Sandra, Bruckmueller, Henrike, Ottmann, Oliver, Pfeifer, Heike, Trautmann, Heiko, Gökbuget, Nicola, Caliebe, Almuth, Kabelitz, Dieter, Kneba, Michael, Horst, Heinz-August, Hoelzer, Dieter, Topp, Max S., Cascorbi, Ingolf, Siebert, Reiner, Brüggemann, Monika
Published in Blood (02.11.2017)
Published in Blood (02.11.2017)
Get full text
Journal Article
Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial
VON TRESCKOW, Bastian, PLÜTSCHOW, Annette, ZIJLSTRA, Josée M, SOEKLER, Martin, STEIN, Harald, EICH, Hans T, MUELLER, Rolf P, DIEHL, Volker, BORCHMANN, Peter, ENGERT, Andreas, FUCHS, Michael, KLIMM, Beate, MARKOVA, Jana, LOHRI, Andreas, KRAL, Zdenek, GREIL, Richard, TOPP, Max S, MEISSNER, Julia
Published in Journal of clinical oncology (20.03.2012)
Published in Journal of clinical oncology (20.03.2012)
Get full text
Journal Article
Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia
Gökbuget, Nicola, Zugmaier, Gerhard, Klinger, Matthias, Kufer, Peter, Stelljes, Matthias, Viardot, Andreas, Horst, Heinz A, Neumann, Svenja, Brüggemann, Monika, Ottmann, Oliver G, Burmeister, Thomas, Wessiepe, Dorothea, Topp, Max S, Bargou, Ralf
Published in Haematologica (Roma) (01.04.2017)
Published in Haematologica (Roma) (01.04.2017)
Get full text
Journal Article
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
Behringer, Karolin, MD, Goergen, Helen, Dipl Math, Hitz, Felicitas, MD, Zijlstra, Josée M, MD, Greil, Richard, MD, Markova, Jana, MD, Sasse, Stephanie, MD, Fuchs, Michael, MD, Topp, Max S, MD, Soekler, Martin, MD, Mathas, Stephan, MD, Meissner, Julia, MD, Wilhelm, Martin, MD, Koch, Peter, MD, Lindemann, Hans-Walter, MD, Schalk, Enrico, MD, Semrau, Robert, MD, Kriz, Jan, MD, Vieler, Tom, MD, Bentz, Martin, MD, Lange, Elisabeth, MD, Mahlberg, Rolf, MD, Hassler, Andre, MD, Vogelhuber, Martin, MD, Hahn, Dennis, MD, Mezger, Jörg, MD, Krause, Stefan W, MD, Skoetz, Nicole, MD, Böll, Boris, MD, von Tresckow, Bastian, MD, Diehl, Volker, MD, Hallek, Michael, MD, Borchmann, Peter, MD, Stein, Harald, MD, Eich, Hans, MD, Engert, Andreas, Dr
Published in The Lancet (British edition) (11.04.2015)
Published in The Lancet (British edition) (11.04.2015)
Get full text
Journal Article
The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78
Rasche, Leo, Duell, Johannes, Morgner, Charlotte, Chatterjee, Manik, Hensel, Frank, Rosenwald, Andreas, Einsele, Hermann, Topp, Max S, Brändlein, Stephanie
Published in PloS one (07.05.2013)
Published in PloS one (07.05.2013)
Get full text
Journal Article
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia
Gökbuget, Nicola, Ihrig, Kristina, Stadler, Michael, Stelljes, Matthias, Elmaagacli, Ahmet, Starck, Michael, Raffel, Simon, Stoltefuss, Andrea, Viardot, Andreas, Kreuzer, Karl-Anton, Heidenreich, Daniela, Renzelmann, Andrea, Wäsch, Ralph, Topp, Max S, Ritter, Barbara, Reimer, Peter, Beck, Joachim, Westermann, Jörg, Wendelin, Knut, Alakel, Nael, Hanoun, Maher, Serve, Hubert, Hoelzer, Dieter
Published in Haematologica (Roma) (01.07.2023)
Published in Haematologica (Roma) (01.07.2023)
Get full text
Journal Article
GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6
Rasche, Leo, Duell, Johannes, Castro, Inês C, Dubljevic, Valentina, Chatterjee, Manik, Knop, Stefan, Hensel, Frank, Rosenwald, Andreas, Einsele, Hermann, Topp, Max S, Brändlein, Stephanie
Published in Haematologica (Roma) (01.03.2015)
Published in Haematologica (Roma) (01.03.2015)
Get full text
Journal Article
Lymphoma-Sink Effect in Marginal Zone Lymphoma Based on CXCR4-Targeted Molecular Imaging
Kosmala, Aleksander, Seifert, Simone, Schneid, Simone, Dreher, Niklas, Higuchi, Takahiro, Weich, Alexander, Serfling, Sebastian E., Hartrampf, Philipp E., Einsele, Hermann, Buck, Andreas K., Topp, Max S., Duell, Johannes, Werner, Rudolf A.
Published in Molecular imaging and biology (01.08.2023)
Published in Molecular imaging and biology (01.08.2023)
Get full text
Journal Article
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study
Shah, Bijal D, Ghobadi, Armin, Oluwole, Olalekan O, Logan, Aaron C, Boissel, Nicolas, Cassaday, Ryan D, Leguay, Thibaut, Bishop, Michael R, Topp, Max S, Tzachanis, Dimitrios, O'Dwyer, Kristen M, Arellano, Martha L, Lin, Yi, Baer, Maria R, Schiller, Gary J, Park, Jae H, Subklewe, Marion, Abedi, Mehrdad, Minnema, Monique C, Wierda, William G, DeAngelo, Daniel J, Stiff, Patrick, Jeyakumar, Deepa, Dong, Jinghui, Adhikary, Sabina, Zhou, Lang, Schuberth, Petra C, Faghmous, Imi, Masouleh, Behzad Kharabi, Houot, Roch
Published in Journal of hematology and oncology (10.12.2022)
Published in Journal of hematology and oncology (10.12.2022)
Get full text
Journal Article
Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma
Topp, Max S, Duell, Johannes, Guijarro, Ana Maria Abajo, Odin, Marielle, Nielsen, Tina, Rajeswaran, Anand, Wenger, Michael, Zundel, Christelle, Bogucka-Fedorczuk, Aleksandra, Wrobel, Tomasz
Published in Haematologica (Roma) (01.05.2020)
Published in Haematologica (Roma) (01.05.2020)
Get full text
Journal Article
Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL
Nägele, Virginie, Kratzer, Andrea, Zugmaier, Gerhard, Holland, Chris, Hijazi, Youssef, Topp, Max S, Gökbuget, Nicola, Baeuerle, Patrick A, Kufer, Peter, Wolf, Andreas, Klinger, Matthias
Published in Experimental hematology & oncology (18.05.2017)
Published in Experimental hematology & oncology (18.05.2017)
Get full text
Journal Article
Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia: Results of a pooled analysis
Topp, Max S., Stein, Anthony S., Gökbuget, Nicola, Horst, Heinz‐August, Boissel, Nicolas, Martinelli, Giovanni, Kantarjian, Hagop, Brüggemann, Monika, Chen, Yuqi, Zugmaier, Gerhard
Published in Cancer medicine (Malden, MA) (01.04.2021)
Published in Cancer medicine (Malden, MA) (01.04.2021)
Get full text
Journal Article
Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases
Rasche, Leo, Bernard, Corinna, Topp, Max S., Kapp, Markus, Duell, Johannes, Wesemeier, Carmen, Haralambieva, Eugenia, Maeder, Uwe, Einsele, Hermann, Knop, Stefan
Published in Annals of hematology (01.07.2012)
Published in Annals of hematology (01.07.2012)
Get full text
Journal Article
Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
Brouwer-Visser, Jurriaan, Fiaschi, Nathalie, Deering, Raquel P, Cygan, Kamil J, Scott, Darius, Jeong, Se, Boucher, Lauren, Gupta, Namita T, Gupta, Suraj, Adler, Christina, Topp, Max S, Bannerji, Rajat, Duell, Johannes, Advani, Ranjana H, Flink, Dina M, Chaudhry, Aafia, Thurston, Gavin, Ambati, Srikanth R, Jankovic, Vladimir
Published in Journal for immunotherapy of cancer (21.03.2024)
Published in Journal for immunotherapy of cancer (21.03.2024)
Get full text
Journal Article